Functional brain imaging using 18F fluorodeoxyglucose (FDG) and positron emission tomography (PET) has greatly enhanced our understanding of brain function both in normal conditions as well as in a wide variety of neuropsychiatric disorders. We review the uses of FDG PET in the diagnosis, management, and follow-up of patients with neuropsychiatric disorders. This article will also explore what FDG-PET imaging has revealed in these neuropsychiatric disorders and how these findings relate to both research and clinical applications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1053/snuc.2002.29276 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!